{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:42:14Z","timestamp":1790635334464,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Suez Canal University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s40291-023-00646-1","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T18:02:49Z","timestamp":1680631369000},"page":"405-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights"],"prefix":"10.1007","volume":"27","author":[{"given":"Hoda Y.","family":"Abdallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Z.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan Hassan","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Kishk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Ellawindy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"issue":"3","key":"646_CR1","doi-asserted-by":"publisher","first-page":"a007260","DOI":"10.1101\/cshperspect.a007260","volume":"4","author":"A Goris","year":"2012","unstructured":"Goris A, Liston A. The immunogenetic architecture of autoimmune disease. Cold Spring Harb Perspect Biol. 2012;4(3):a007260. https:\/\/doi.org\/10.1101\/cshperspect.a007260.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"646_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7748\/ns2012.10.27.7.35.c9358","volume":"27","author":"E McLafferty","year":"2012","unstructured":"McLafferty E, Hendry C, Alistair F. The integumentary system: anatomy, physiology and function of skin. Nurs Stand. 2012;27(3):35\u201342. https:\/\/doi.org\/10.7748\/ns2012.10.27.7.35.c9358.","journal-title":"Nurs Stand"},{"issue":"4","key":"646_CR3","first-page":"203","volume":"3","author":"PA Kolarsick","year":"2011","unstructured":"Kolarsick PA, Kolarsick MA, Goodwin C. Anatomy and physiology of the skin. JDNA. 2011;3(4):203\u201313.","journal-title":"JDNA."},{"issue":"2","key":"646_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0192623311428481","volume":"40","author":"B Bolon","year":"2012","unstructured":"Bolon B. Cellular and molecular mechanisms of autoimmune disease. Toxicol Pathol. 2012;40(2):216\u201329. https:\/\/doi.org\/10.1177\/0192623311428481.","journal-title":"Toxicol Pathol"},{"issue":"4","key":"646_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.gpb.2015.04.002","volume":"13","author":"S Jiang","year":"2015","unstructured":"Jiang S, Hinchliffe TE, Wu T. Biomarkers of an autoimmune skin disease-psoriasis. Genom Proteom Bioinform. 2015;13(4):224\u201333. https:\/\/doi.org\/10.1016\/j.gpb.2015.04.002.","journal-title":"Genom Proteom Bioinform"},{"key":"646_CR6","doi-asserted-by":"crossref","unstructured":"Albanesi C. Immunology of psoriasis. In: Immunology (Fifth Edition), Principles and Practice, 2019, pp 871-878.e1. https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780702068966000648","DOI":"10.1016\/B978-0-7020-6896-6.00064-8"},{"key":"646_CR7","doi-asserted-by":"publisher","first-page":"711080","DOI":"10.3389\/fimmu.2021.711080","volume":"12","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Harris JE, Le Poole IC, Passeron T, Speeckaert R, Boniface K. Editorial: immunology of vitiligo. Front Immunol. 2021;12:711080. https:\/\/doi.org\/10.3389\/fimmu.2021.711080.","journal-title":"Front Immunol"},{"issue":"5","key":"646_CR8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/bjd.14703","volume":"175","author":"R Speeckaert","year":"2016","unstructured":"Speeckaert R, Lambert J, Grine L, Van Gele M, De Schepper S, van Geel N. The many faces of interleukin-17 in inflammatory skin diseases. Br J Dermatol. 2016;175(5):892\u2013901. https:\/\/doi.org\/10.1111\/bjd.14703.","journal-title":"Br J Dermatol"},{"issue":"1","key":"646_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0394-1","volume":"20","author":"H Yen","year":"2019","unstructured":"Yen H, Chi CC. Association between psoriasis and vitiligo: a systematic review and meta-analysis. Am J Clin Dermatol. 2019;20(1):31\u201340. https:\/\/doi.org\/10.1007\/s40257-018-0394-1.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"646_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2340\/00015555-1713","volume":"94","author":"S Ono","year":"2014","unstructured":"Ono S, Tanizaki H, Otsuka A, et al. Coexistent skin lesions of vitiligo and psoriasis vulgaris. Immunohistochemical analyses for IL-17A-producing cells and regulatory T cells. Acta Derm Venereol. 2014;94(3):329\u201330. https:\/\/doi.org\/10.2340\/00015555-1713.","journal-title":"Acta Derm Venereol"},{"key":"646_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2019.01.001","volume":"45","author":"D Das","year":"2019","unstructured":"Das D, Akhtar S, Kurra S, Gupta S, Sharma A. Emerging role of immune cell network in autoimmune skin disorders: an update on pemphigus, vitiligo and psoriasis. Cytokine Growth Factor Rev. 2019;45:35\u201344. https:\/\/doi.org\/10.1016\/j.cytogfr.2019.01.001.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"646_CR12","doi-asserted-by":"publisher","first-page":"102761","DOI":"10.1016\/j.autrev.2021.102761","volume":"20","author":"Z Mukhatayev","year":"2021","unstructured":"Mukhatayev Z, Ostapchuk YO, Fang D, Le Poole IC. Engineered antigen-specific regulatory T cells for autoimmune skin conditions. Autoimmun Rev. 2021;20(3):102761. https:\/\/doi.org\/10.1016\/j.autrev.2021.102761.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"646_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7241\/ourd.20204.13","volume":"11","author":"C Sharon","year":"2020","unstructured":"Sharon C, Jiquan S. Association of NLRP1 and NLRP3 gene polymorphism with psoriasis. Our Dermatol Online. 2020;11(3):275\u201383. https:\/\/doi.org\/10.7241\/ourd.20204.13.","journal-title":"Our Dermatol Online."},{"issue":"31","key":"646_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2021.101002","volume":"1","author":"AA Saleh","year":"2022","unstructured":"Saleh AA, Shehata WA, Abd-Elhafiz HI, Soliman SE. Potential impact of TNFAIP3 rs6920220 and DEFB1 rs1800972 gene polymorphisms on vitiligo in Egyptian patients. Meta Gene. 2022;1(31): 101002.","journal-title":"Meta Gene."},{"issue":"1","key":"646_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2003.12.014","volume":"51","author":"K Sandhu","year":"2004","unstructured":"Sandhu K, Kaur I, Kumar B. Psoriasis and vitiligo. J Am Acad Dermatol. 2004;51(1):149\u201350. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.014.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"646_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7241\/ourd.20213.21","volume":"12","author":"KE Sharquie","year":"2021","unstructured":"Sharquie KE, Sharquie IK, Al Hamza AN. Psoriasis, pityriasis alba, and vitiligo (PPV) are a triad of one disease: new observation. Our Dermatol Online. 2021;12(3):314\u201323. https:\/\/doi.org\/10.7241\/ourd.20213.21.","journal-title":"Our Dermatol Online."},{"issue":"2","key":"646_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clindermatol.2010.09.014","volume":"29","author":"L Sagi","year":"2011","unstructured":"Sagi L, Trau H. The Koebner phenomenon. Clin Dermatol. 2011;29(2):231\u20136. https:\/\/doi.org\/10.1016\/j.clindermatol.2010.09.014.","journal-title":"Clin Dermatol"},{"issue":"4","key":"646_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jdv.12117","volume":"28","author":"M Arunachalam","year":"2014","unstructured":"Arunachalam M, Dragoni F, Colucci R, et al. Non-segmental vitiligo and psoriasis comorbidity - a case-control study in Italian patients. J Eur Acad Dermatol Venereol. 2014;28(4):433\u20137. https:\/\/doi.org\/10.1111\/jdv.12117.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"646_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tig.2005.03.007","volume":"21","author":"A H\u00fcttenhofer","year":"2005","unstructured":"H\u00fcttenhofer A, Schattner P, Polacek N. Non-coding RNAs: hope or hype? Trends Genet. 2005;21(5):289\u201397. https:\/\/doi.org\/10.1016\/j.tig.2005.03.007.","journal-title":"Trends Genet"},{"issue":"3","key":"646_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/07853890701771823","volume":"40","author":"DJ Guarnieri","year":"2008","unstructured":"Guarnieri DJ, DiLeone RJ. MicroRNAs: a new class of gene regulators. Ann Med. 2008;40(3):197\u2013208. https:\/\/doi.org\/10.1080\/07853890701771823.","journal-title":"Ann Med"},{"issue":"15","key":"646_CR21","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/onc.2010.59","volume":"29","author":"ME Peter","year":"2010","unstructured":"Peter ME. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene. 2010;29(15):2161\u20134. https:\/\/doi.org\/10.1038\/onc.2010.59.","journal-title":"Oncogene"},{"issue":"10","key":"646_CR22","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/ijms17101712","volume":"17","author":"C Catalanotto","year":"2016","unstructured":"Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci. 2016;17(10):1712. https:\/\/doi.org\/10.3390\/ijms17101712.\u00a0","journal-title":"Int J Mol Sci"},{"issue":"3","key":"646_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/sji.12261","volume":"81","author":"X Deng","year":"2015","unstructured":"Deng X, Su Y, Wu H, et al. The role of microRNAs in autoimmune diseases with skin involvement. Scand J Immunol. 2015;81(3):153\u201365. https:\/\/doi.org\/10.1111\/sji.12261.","journal-title":"Scand J Immunol"},{"key":"646_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semcancer.2020.07.003","volume":"83","author":"AQ Khan","year":"2022","unstructured":"Khan AQ, Ahmad F, Raza SS, et al. Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases. Semin Cancer Biol. 2022;83:208\u201326. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.003.","journal-title":"Semin Cancer Biol"},{"issue":"Database issue","key":"646_CR25","doi-asserted-by":"publisher","first-page":"D98","DOI":"10.1093\/nar\/gkn714","volume":"37","author":"Q Jiang","year":"2009","unstructured":"Jiang Q, Wang Y, Hao Y, et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009;37(Database issue):D98\u2013104. https:\/\/doi.org\/10.1093\/nar\/gkn714.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"646_CR26","doi-asserted-by":"publisher","first-page":"D1013","DOI":"10.1093\/nar\/gky1010","volume":"47","author":"Z Huang","year":"2019","unstructured":"Huang Z, Shi J, Gao Y, et al. HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res. 2019;47(D1):D1013\u20137. https:\/\/doi.org\/10.1093\/nar\/gky1010.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"646_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"3","key":"646_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/omi.2015.0168","volume":"20","author":"S Ben-Ari Fuchs","year":"2016","unstructured":"Ben-Ari Fuchs S, Lieder I, Stelzer G, et al. GeneAnalytics: an integrative gene set analysis tool for next generation sequencing. RNAseq and Microarray Data OMICS. 2016;20(3):139\u201351. https:\/\/doi.org\/10.1089\/omi.2015.0168.","journal-title":"RNAseq and Microarray Data. OMICS."},{"issue":"2","key":"646_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12864-016-2722-2","volume":"17","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Plaschkes I, Oz-Levi D, Alkelai A, Olender T, Zimmerman S, Twik M, Belinky F, Fishilevich S, Nudel R, Guan-Golan Y. VarElect: the phenotype-based variation prioritizer of the GeneCards Suite. BMC Genomics. 2016;17(2):195\u2013206. https:\/\/doi.org\/10.1186\/s12864-016-2722-2.","journal-title":"BMC Genomics"},{"key":"646_CR30","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2003-4-9-r60","volume":"4","author":"G Dennis","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:R60. https:\/\/doi.org\/10.1186\/gb-2003-4-9-r60.","journal-title":"Genome Biol"},{"key":"646_CR31","doi-asserted-by":"publisher","unstructured":"Vlachos IS, Zagganas K, Paraskevopoulou MD, et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43(W1):W460-W466. https:\/\/doi.org\/10.1093\/nar\/gkv403","DOI":"10.1093\/nar\/gkv403"},{"issue":"W1","key":"646_CR32","doi-asserted-by":"publisher","first-page":"W409","DOI":"10.1093\/nar\/gkab297","volume":"49","author":"F Kern","year":"2021","unstructured":"Kern F, Aparicio-Puerta E, Li Y, et al. miRTargetLink 2.0-interactive miRNA target gene and target pathway networks. Nucleic Acids Res. 2021;49(W1):W409\u201316. https:\/\/doi.org\/10.1093\/nar\/gkab297.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"646_CR33","doi-asserted-by":"publisher","first-page":"e676","DOI":"10.1111\/jdv.17383","volume":"35","author":"D Canu","year":"2021","unstructured":"Canu D, Shourick J, Andreu N, et al. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study. J Eur Acad Dermatol Venereol. 2021;35(10):e676\u20139. https:\/\/doi.org\/10.1111\/jdv.17383.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"646_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402.PMID:30123182;PMCID:PMC6085463","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402.PMID:30123182;PMCID:PMC6085463.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"646_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/cdd.2009.92","volume":"17","author":"R Yi","year":"2010","unstructured":"Yi R, Fuchs E. MicroRNA-mediated control in the skin. Cell Death Differ. 2010;17(2):229\u201335. https:\/\/doi.org\/10.1038\/cdd.2009.92.","journal-title":"Cell Death Differ"},{"key":"646_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.biopha.2018.09.090","volume":"108","author":"G Singhvi","year":"2018","unstructured":"Singhvi G, Manchanda P, Krishna Rapalli V, Kumar Dubey S, Gupta G, Dua K. MicroRNAs as biological regulators in skin disorders Biomed. Pharmacother. 2018;108:996\u20131004. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.090.","journal-title":"Pharmacother"},{"key":"646_CR37","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1002\/hsr2.374","volume":"4","author":"X Li","year":"2021","unstructured":"Li X, Ponandai-Srinivasan S, Nandakumar KS, et al. Targeting microRNA for improved skin health. Health Sci Rep. 2021;4:e374. https:\/\/doi.org\/10.1002\/hsr2.374.","journal-title":"Health Sci Rep."},{"issue":"16","key":"646_CR38","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.3390\/ijms21165781","volume":"21","author":"A-Y Lee","year":"2020","unstructured":"Lee A-Y. The role of microRNAs in epidermal barrier. Int J Mol Sci. 2020;21(16):5781. https:\/\/doi.org\/10.3390\/ijms21165781.","journal-title":"Int J Mol Sci"},{"key":"646_CR39","doi-asserted-by":"publisher","first-page":"100955","DOI":"10.1016\/j.genrep.2020.100955","volume":"21","author":"YW Issa","year":"2020","unstructured":"Issa YW, Salih SM. Impact of miRNA-155, miRNA-145 and miRNA-328 on pigmentary process in Iraqi patients with vitiligo. Gene Rep. 2020;21:100955. https:\/\/doi.org\/10.1016\/j.genrep.2020.100955.","journal-title":"Gene Rep."},{"issue":"6","key":"646_CR40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2340\/00015555-2394","volume":"96","author":"L \u0160ahmatova","year":"2016","unstructured":"\u0160ahmatova L, Tankov S, Prans E, et al. MicroRNA-155 is dysregulated in the skin of patients with vitiligo and inhibits melanogenesis-associated genes in melanocytes and keratinocytes. Acta Derm Venereol. 2016;96(6):742\u20137. https:\/\/doi.org\/10.2340\/00015555-2394.","journal-title":"Acta Derm Venereol"},{"key":"646_CR41","doi-asserted-by":"publisher","first-page":"E289","DOI":"10.3390\/ijms18020289","volume":"18","author":"A Kempinska-Podhorodecka","year":"2017","unstructured":"Kempinska-Podhorodecka A, Milkiewicz M, Wasik U, Ligocka J, Zawadzki M, Krawczyk M, Milkiewicz P. Decreased expression of vitamin D receptor affects an immune response in primary biliary cholangitis via the VDR-miRNA155-SOCS1 pathway. Int J Mol Sci. 2017;18:E289. https:\/\/doi.org\/10.3390\/ijms18020289.","journal-title":"Int J Mol Sci"},{"key":"646_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/jmcb\/mjs040","volume":"4","author":"Q Lan","year":"2012","unstructured":"Lan Q, Zhou X, Fan H, Chen M, Wang J, Ryffel B, Brand D, Ramalingam R, Kiela PR, Horwitz DA, et al. Polyclonal CD4+Foxp3+ Treg cells induce TGF\u03b2-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome. J Mol Cell Biol. 2012;4:409\u201319. https:\/\/doi.org\/10.1093\/jmcb\/mjs040.","journal-title":"J Mol Cell Biol"},{"issue":"4","key":"646_CR43","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3892\/mmr.2019.10607","volume":"20","author":"M Lv","year":"2019","unstructured":"Lv M, Li Z, Liu J, et al. MicroRNA 155 inhibits the proliferation of CD8+ T cells via upregulating regulatory T cells in vitiligo. Mol Med Rep. 2019;20(4):3617\u201324. https:\/\/doi.org\/10.3892\/mmr.2019.10607.","journal-title":"Mol Med Rep"},{"issue":"4","key":"646_CR44","doi-asserted-by":"publisher","first-page":"e0122517","DOI":"10.1371\/journal.pone.0122517","volume":"10","author":"N Arts","year":"2015","unstructured":"Arts N, Can\u00e9 S, Hennequart M, et al. microRNA-155, induced by interleukin-1\u00df, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. PLoS ONE. 2015;10(4):e0122517. https:\/\/doi.org\/10.1371\/journal.pone.0122517.","journal-title":"PLoS ONE"},{"issue":"4","key":"646_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-0749.2004.00164.x","volume":"17","author":"KW Vance","year":"2004","unstructured":"Vance KW, Goding CR. The transcription network regulating melanocyte development and melanoma. Pigment Cell Res. 2004;17(4):318\u201325. https:\/\/doi.org\/10.1111\/j.1600-0749.2004.00164.x.","journal-title":"Pigment Cell Res"},{"issue":"1","key":"646_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/bjd.18890","volume":"183","author":"AS Parihar","year":"2020","unstructured":"Parihar AS, Tembhre MK, Sharma VK, Gupta S, Chattopadhyay P, Deepak KK. Effect of narrowband ultraviolet B treatment on microRNA expression in active nonsegmental generalized vitiligo. Br J Dermatol. 2020;183(1):167\u20139. https:\/\/doi.org\/10.1111\/bjd.18890. (Epub 2020 Mar 11 PMID: 31975367).","journal-title":"Br J Dermatol"},{"issue":"5","key":"646_CR47","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/bjd.13109","volume":"171","author":"MS Mansuri","year":"2014","unstructured":"Mansuri MS, Singh M, Dwivedi M, Laddha NC, Marfatia YS, Begum R. MicroRNA profiling reveals differentially expressed microRNA signatures from the skin of patients with nonsegmental vitiligo. Br J Dermatol. 2014;171(5):1263\u20137. https:\/\/doi.org\/10.1111\/bjd.13109.","journal-title":"Br J Dermatol"},{"issue":"1","key":"646_CR48","doi-asserted-by":"publisher","first-page":"111615","DOI":"10.1016\/j.yexcr.2019.111615","volume":"384","author":"M Su","year":"2019","unstructured":"Su M, Yi H, He X, Luo L, Jiang S, Shi Y. miRNA-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment. Exp Cell Res. 2019;384(1):111615. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111615.","journal-title":"Exp Cell Res"},{"issue":"3","key":"646_CR49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/exd.14487","volume":"31","author":"NMA Raia","year":"2022","unstructured":"Raia NMA, Shaker OG, Hassan ZM, Abd Elrahim TA. Is there a relation between long non-coding RNA MALAT-1 and miRNA-9 in Egyptian patients with Vitiligo? Exp Dermatol. 2022;31(3):381\u20133. https:\/\/doi.org\/10.1111\/exd.14487.","journal-title":"Exp Dermatol"},{"key":"646_CR50","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.2147\/OTT.S225120","volume":"12","author":"C Shen","year":"2019","unstructured":"Shen C, Hua H, Gu L, et al. miRNA-124 functions as a melanoma tumor suppressor by targeting RACK1. Onco Targets Ther. 2019;12:9975\u201386. https:\/\/doi.org\/10.2147\/OTT.S225120.","journal-title":"Onco Targets Ther"},{"issue":"22","key":"646_CR51","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.3390\/ijms20225731","volume":"20","author":"CM Failla","year":"2019","unstructured":"Failla CM, Carbone ML, Fortes C, Pagnanelli G, D\u2019Atri S. Melanoma and vitiligo: in good company. Int J Mol Sci. 2019;20(22):5731. https:\/\/doi.org\/10.3390\/ijms20225731.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"646_CR52","doi-asserted-by":"publisher","first-page":"13526","DOI":"10.1038\/s41598-022-17770-3","volume":"12","author":"HY Abdallah","year":"2022","unstructured":"Abdallah HY, Abdelhamid NR, Mohammed EA, et al. Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo. Sci Rep. 2022;12(1):13526. https:\/\/doi.org\/10.1038\/s41598-022-17770-3.\u00a0","journal-title":"Sci Rep"},{"issue":"4","key":"646_CR53","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","volume":"97","author":"HZ Marchioro","year":"2022","unstructured":"Marchioro HZ, Silva de Castro CC, Fava VM, Sakiyama PH, Dellatorre G, Miot HA. Update on the pathogenesis of vitiligo. An Bras Dermatol. 2022;97(4):478\u201390. https:\/\/doi.org\/10.1016\/j.abd.2021.09.008.","journal-title":"An Bras Dermatol"},{"issue":"1","key":"646_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/jid.2010.268","volume":"131","author":"J Hildebrand","year":"2011","unstructured":"Hildebrand J, R\u00fctze M, Walz N, et al. A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol. 2011;131(1):20\u20139. https:\/\/doi.org\/10.1038\/jid.2010.268.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"646_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jdermsci.2010.03.004","volume":"58","author":"JR Zibert","year":"2010","unstructured":"Zibert JR, L\u00f8vendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci. 2010;58(3):177\u201385. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.03.004.","journal-title":"J Dermatol Sci"},{"issue":"7","key":"646_CR56","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","volume":"2","author":"E Sonkoly","year":"2007","unstructured":"Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE. 2007;2(7):e610. https:\/\/doi.org\/10.1371\/journal.pone.0000610.\u00a0","journal-title":"PLoS ONE"},{"issue":"20","key":"646_CR57","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1093\/hmg\/ddr331","volume":"20","author":"CE Joyce","year":"2011","unstructured":"Joyce CE, Zhou X, Xia J, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet. 2011;20(20):4025\u201340. https:\/\/doi.org\/10.1093\/hmg\/ddr331.","journal-title":"Hum Mol Genet"},{"key":"646_CR58","doi-asserted-by":"publisher","first-page":"988962","DOI":"10.3389\/fmed.2022.988962","volume":"9","author":"SA Mostafa","year":"2022","unstructured":"Mostafa SA, Mohammad MHS, Negm WA, et al. Circulating microRNA203 and its target genes\u2019 role in psoriasis pathogenesis. Front Med (Lausanne). 2022;9:988962. https:\/\/doi.org\/10.3389\/fmed.2022.988962.\u00a0","journal-title":"Front Med (Lausanne)."},{"issue":"3","key":"646_CR59","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.cyto.2012.07.031","volume":"60","author":"MN Primo","year":"2012","unstructured":"Primo MN, Bak RO, Schibler B, Mikkelsen JG. Regulation of pro-inflammatory cytokines TNF\u03b1 and IL24 by microRNA-203 in primary keratinocytes. Cytokine. 2012;60(3):741\u20138. https:\/\/doi.org\/10.1016\/j.cyto.2012.07.031.","journal-title":"Cytokine"},{"issue":"1","key":"646_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/jid.2009.294","volume":"130","author":"E Sonkoly","year":"2010","unstructured":"Sonkoly E, Wei T, Pavez Lori\u00e8 E, et al. Protein kinase C-dependent upregulation of miRNA-203 induces the differentiation of human keratinocytes. J Invest Dermatol. 2010;130(1):124\u201334. https:\/\/doi.org\/10.1038\/jid.2009.294.","journal-title":"J Invest Dermatol"},{"key":"646_CR61","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1080\/15384101.2020.1783934","volume":"19","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Wang H, Wang C, Zeng B, Tang X, Zhang Y, et al. miRNA-203 promotes HaCaT cell overproliferation through targeting LXR-\u03b1 and PPAR-\u03b3. Cell Cycle. 2020;19:1928\u201340. https:\/\/doi.org\/10.1080\/15384101.2020.1783934.","journal-title":"Cell Cycle"},{"issue":"4","key":"646_CR62","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbrc.2019.04.051","volume":"513","author":"JN Deng","year":"2019","unstructured":"Deng JN, Li YQ, Liu Y, et al. Exosomes derived from plasma of septic patients inhibit apoptosis of T lymphocytes by down-regulating bad via hsa-miRNA-7-5p. Biochem Biophys Res Commun. 2019;513(4):958\u201366. https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.051.","journal-title":"Biochem Biophys Res Commun"},{"key":"646_CR63","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.biopha.2017.03.105","volume":"90","author":"L Xu","year":"2017","unstructured":"Xu L, Leng H, Shi X, Ji J, Fu J, Leng H. MiRNA-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis. Biomed Pharmacother. 2017;90:524\u201330. https:\/\/doi.org\/10.1016\/j.biopha.2017.03.105.","journal-title":"Biomed Pharmacother"},{"key":"646_CR64","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/exd.14117","volume":"29","author":"H Wang","year":"2020","unstructured":"Wang H, Zhang Y, Luomei J, Huang P, Zhou R, Peng Y. The miRNA-155\/GATA3\/IL37 axis modulates the production of proinflammatory cytokines upon TNF-\u03b1 stimulation to affect psoriasis development. Exp Dermatol. 2020;29:647\u201358. https:\/\/doi.org\/10.1111\/exd.14117.","journal-title":"Exp Dermatol"},{"key":"646_CR65","doi-asserted-by":"publisher","first-page":"205873842093374","DOI":"10.1177\/2058738420933742","volume":"34","author":"M El-Komy","year":"2020","unstructured":"El-Komy M, Amin I, El-Hawary MS, Saadi D, Shaker O. Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis patients and their relation to IL-17. Int J Immunopathol Pharmacol. 2020;34:2058738420933742. https:\/\/doi.org\/10.1177\/2058738420933742.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"646_CR66","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jdv.13861","volume":"31","author":"S Garc\u00eda-Rodr\u00edguez","year":"2017","unstructured":"Garc\u00eda-Rodr\u00edguez S, Arias-Santiago S, Blasco-Morente G, Orgaz-Molina J, Rosal-Vela A, Navarro P, et al. Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity. J Eur Acad Dermatol Venereol. 2017;31:312\u201322. https:\/\/doi.org\/10.1111\/jdv.13861.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"646_CR67","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/ijd.12061","volume":"53","author":"Y Li","year":"2014","unstructured":"Li Y, Man X, You L, Xiang Q, Li H, Xu B, et al. Downregulation of PTEN expression in psoriatic lesions. Int J Dermatol. 2014;53:855\u201360. https:\/\/doi.org\/10.1111\/ijd.12061.","journal-title":"Int J Dermatol"},{"issue":"2","key":"646_CR68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/bjd.17256","volume":"180","author":"JJ Yan","year":"2019","unstructured":"Yan JJ, Qiao M, Li RH, Zhao XT, Wang XY, Sun Q. Downregulation of miRNA-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis. Br J Dermatol. 2019;180(2):365\u201372. https:\/\/doi.org\/10.1111\/bjd.17256.","journal-title":"Br J Dermatol"},{"issue":"9","key":"646_CR69","first-page":"10439","volume":"13","author":"Y Wang","year":"2021","unstructured":"Wang Y, Cao Y. miRNA-145-5p inhibits psoriasis progression by regulating the Wnt\/\u03b2-catenin pathway. Am J Transl Res. 2021;13(9):10439\u201348 (PMID: 34650713; PMCID: PMC8507052).","journal-title":"Am J Transl Res."},{"issue":"8","key":"646_CR70","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/1440-1681.13103","volume":"46","author":"X Yu","year":"2019","unstructured":"Yu X, Yan N, Li Z, Hua Y, Chen W. FGF19 sustains the high proliferative ability of keratinocytes in psoriasis through the regulation of Wnt\/GSK-3\u03b2\/\u03b2-catenin signalling via FGFR4. Clin Exp Pharmacol Physiol. 2019;46(8):761\u20139. https:\/\/doi.org\/10.1111\/1440-1681.13103.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"646_CR71","doi-asserted-by":"publisher","first-page":"101030","DOI":"10.1016\/j.bbrep.2021.101030","volume":"26","author":"AM Elamir","year":"2021","unstructured":"Elamir AM, Shaker OG, El-Komy MH, Mahmoud Sharabi M, Aboraia NM. The role of LncRNA MALAT-1 and MiRNA-9 in psoriasis. Biochem Biophys Rep. 2021;26:101030. https:\/\/doi.org\/10.1016\/j.bbrep.2021.101030.","journal-title":"Biochem Biophys Rep."},{"issue":"7","key":"646_CR72","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/cells9071603","volume":"9","author":"P Chicharro","year":"2020","unstructured":"Chicharro P, Rodr\u00edguez-Jim\u00e9nez P, Llamas-Velasco M, et al. Expression of miRNA-135b in psoriatic skin and its association with disease improvement. Cells. 2020;9(7):1603. https:\/\/doi.org\/10.3390\/cells9071603.\u00a0","journal-title":"Cells"},{"key":"646_CR73","doi-asserted-by":"publisher","first-page":"e1538","DOI":"10.1002\/mgg3.1538","volume":"8","author":"F Shirani","year":"2022","unstructured":"Shirani F, Baghi M, Rostamian Delavar M, Shoaraye Nejati A, Eshaghiyan A, Nasr-Esfahani MH, Peymani M, Ghaedi K. Upregulation of miRNA-9 and miRNA-193b over human Th17 cell differentiation. Mol Genet Genomic Med. 2022;8:e1538. https:\/\/doi.org\/10.1002\/mgg3.1538.","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"646_CR74","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40291-022-00598-y","volume":"26","author":"HY Abdallah","year":"2022","unstructured":"Abdallah HY, Tawfik NZ, Soliman NH, Eldeen LAT. The lncRNA PRINS-miRNA-mRNA axis gene expression profile as a circulating biomarker panel in psoriasis. Mol Diagn Ther. 2022;26(4):451\u201365. https:\/\/doi.org\/10.1007\/s40291-022-00598-y.","journal-title":"Mol Diagn Ther"},{"key":"646_CR75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/JIR.S137606","volume":"11","author":"A Negroni","year":"2018","unstructured":"Negroni A, Pierdomenico M, Cucchiara S, Stronati L. NOD2 and inflammation: current insights. J Inflamm Res. 2018;11:49\u201360. https:\/\/doi.org\/10.2147\/JIR.S137606.","journal-title":"J Inflamm Res"},{"issue":"7","key":"646_CR76","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fcell.2019.00068","volume":"7","author":"O Bhattacharjee","year":"2019","unstructured":"Bhattacharjee O, Ayyangar U, Kurbet AS, Ashok D, Raghavan S. Unraveling the ECM-immune cell crosstalk in skin diseases. Front Cell Dev Biol. 2019;7(7):68. https:\/\/doi.org\/10.3389\/fcell.2019.00068.","journal-title":"Front Cell Dev Biol."},{"issue":"21","key":"646_CR77","doi-asserted-by":"publisher","first-page":"11429","DOI":"10.3390\/ijms222111429","volume":"22","author":"P Custurone","year":"2021","unstructured":"Custurone P, Di Bartolomeo L, Irrera N, Borgia F, Altavilla D, Bitto A, Pallio G, Squadrito F, Vaccaro M. Role of cytokines in vitiligo: pathogenesis and possible targets for old and new treatments. Int J Mol Sci. 2021;22(21):11429. https:\/\/doi.org\/10.3390\/ijms222111429.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"646_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13(1):81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3.","journal-title":"Cell Death Dis"},{"key":"646_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/484696","author":"MD Williams","year":"2012","unstructured":"Williams MD, Mitchell GM. MicroRNAs in insulin resistance and obesity. Exp Diabetes Res. 2012. https:\/\/doi.org\/10.1155\/2012\/484696.","journal-title":"Exp Diabetes Res"},{"key":"646_CR80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12263-017-0577-z","volume":"12","author":"G Iacomino","year":"2017","unstructured":"Iacomino G, Siani A. Role of microRNAs in obesity and obesity-related diseases. Genes Nutr. 2017;12:23. https:\/\/doi.org\/10.1186\/s12263-017-0577-z.","journal-title":"Genes Nutr"},{"issue":"8","key":"646_CR81","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/cells8080859","volume":"8","author":"JF Landrier","year":"2019","unstructured":"Landrier JF, Derghal A, Mounien L. MicroRNAs in obesity and related metabolic disorders. Cells. 2019;8(8):859. https:\/\/doi.org\/10.3390\/cells8080859.","journal-title":"Cells"},{"key":"646_CR82","doi-asserted-by":"publisher","first-page":"563816","DOI":"10.3389\/fendo.2020.563816","volume":"11","author":"GS Heyn","year":"2020","unstructured":"Heyn GS, Corr\u00eaa LH, Magalh\u00e3es KG. The impact of adipose tissue\u2013derived miRNAs in metabolic syndrome, obesity, and cancer. Front Endocrinol. 2020;11:563816. https:\/\/doi.org\/10.3389\/fendo.2020.563816.","journal-title":"Front Endocrinol"},{"key":"646_CR83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.arr.2014.04.005","volume":"17","author":"JD almer","year":"2014","unstructured":"almer JD, Soule BP, Simone BA, Zaorsky NG, Jin L, Simone NL. MicroRNA expression altered by diet: Can food be medicinal? Ageing Res Rev. 2014;17:16\u201324. https:\/\/doi.org\/10.1016\/j.arr.2014.04.005.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"646_CR84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13679-020-00397-8","volume":"9","author":"C Tsigalou","year":"2020","unstructured":"Tsigalou C, Vallianou N, Dalamaga M. Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity? Curr Obes Rep. 2020;9(3):245\u201354. https:\/\/doi.org\/10.1007\/s13679-020-00397-8. (PMID: 32632847).","journal-title":"Curr Obes Rep"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-023-00646-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T03:32:00Z","timestamp":1682998320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-023-00646-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1007\/s40291-023-00646-1","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"28 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Committee of Ethics approval no 5091 was granted from the Faculty of Medicine, Suez Canal University, Ismailia, Egypt, and the study was conducted according to the Declaration of Helsinki\u2019s guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"AHY, EA and TNZ designed the study, TNZ collected the clinical data, SNH collected the patients\u2019 samples, AHY, ElA, KRM, FS, and SNH carried out the experiments, AHY, EA, KiRM, FS and SNH analyzed and interpreted the patient data. All authors discussed the results, contributed to the final manuscript and approved it.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}},{"value":"Abdallah HY, Faisal S, Tawfik NZ, Soliman NH, Kishk RM, and Ellawindy A declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest statement"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}